Biotechnology Stocks I Performance Guide: Blueprint Medicines Corporation (BPMC)
BPMC has no dividends
Table and Chart of BPMC Performance
See what a $1,000 investment in BPMC is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| BPMC Returns | |
|---|---|
| Start Date | May-29-2015 |
| Start Price | $28.69 |
| End Date | Dec-01-2023 |
| End Price | $72.05 |
| # Prices | 104 |
| Min Date | Apr-29-2016 |
| Min Price | $15.18 |
| Max Date | Oct-29-2021 |
| Max Price | $112.49 |
| Total Return | 151.13% |
| Annualized Return | 11.21% |
| Current Value of $1,000 Purchase | $2,511 |
| Number Returns | 5,356 |
| Average Return | 73.74% |
| Number Profitable Returns | 3,537 |
| Percent Profitable Returns | 66.04% |
| Number Unprofitable Returns | 1,819 |
| Percent Unprofitable Returns | 33.96% |
| Profitable to Unprofitable Returns Ratio | 1.94 |
| BPMC Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $4,379,898,000 | Price to Sales | 20.26 |
| Earnings per Share | $-9.2000 |
| PE Ratio | None |
| PE to Growth Ratio | 0 |
| Price to Book | 21.64 |
| PRICE DATA | |
| 52 Week High | $72.14 |
| 52 Week Low | $37.82 |
| Analyst Target Price | $79.5 |
| 50-Day Moving Average | $55.82 |
| 200-Day Moving Average | $52.93 |
| FINANCIAL DATA | |
| Revenue per Share | $3.585 |
| Revenue | $216,204,000 |
| Profit Margin | -256.6% |
| Return on Equity | -1.316% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
BPMC Compare Returns with S&P 500
BPMC Trendline Chart